This study is not yet accepting patients
SPI-1005 for the Treatment of Meniere's Disease
Summary
- Eligibility
- for people ages 18-75 (full criteria)
- Location
- at San Francisco, California and other locations
- Dates
- study startedestimated completion
Description
Summary
Official Title
Keywords
Eligibility
Locations
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- Sound Pharmaceuticals, Incorporated
- ID
- NCT04677972
- Phase
- Phase 3
- Study Type
- Interventional
- Last Updated